About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 1NCT03082053

A Study of Varlitinib in Japanese Subjects With Advanced or Metastatic Solid Tumours

The purpose of this study is to explore safety and efficacy of varlitinib administered as monotherapy in Japanese subjects with advanced or metastatic solid tumors, and administered as combination wit...

Lead sponsor: ASLAN Pharmaceuticals•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

ASLAN Pharmaceuticals

Age

20 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Study I: Subjects with a solid tumour (excluding haematologic tumors) in advanced or metastatic stage
•Study II: Subjects with advanced (unresectable) or metastatic biliary tract cancer (IHCC, EHCC, gallbladder cancer or ampullary carcinoma)

Exclusion Criteria

•Subjects with concurrent multiple primary cancers.
•Subjects with a history of (non-infectious) pneumonitis that required steroids or current pneumonitis, or with a history of interstitial lung disease or current interstitial lung disease
•Subjects receiving proton pump inhibitors for established, symptomatic gastro-duodenal ulceration or gastroesophageal reflux disease (including the preventive use)

Related studies

RECRUITINGPhase 1

A Clinical Study of KK2260 in Patients With Advanced or Metastatic Solid Tumors

NCT06248411 · Advanced or Metastatic Solid Tumors

RECRUITINGPhase 1

A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors

NCT06307795 · Locally Advanced or Metastatic Solid Tumors

RECRUITINGPhase 1

A Study to Investigate ANS03 in Participants With Locally Advanced or Metastatic Solid Tumors

NCT06716138 · Locally Advanced or Metastatic Solid Tumors Harboring a ROS1 or NTRK Alteration

RECRUITINGPhase 1

A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies

NCT05753722 · Advanced or Metastatic Solid Tumors, Non Small Cell Lung Cancer, and more

RECRUITINGPhase 1

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors

NCT05581004 · Locally Advanced or Metastatic Solid Tumors, NSCLC, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 28, 2018Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment24

Start dateJan 2017

Last updatedJun 28, 2018

Condition

Advanced or Metastatic Biliary Tract Cancer Advanced or Metastatic Solid Tumors

Locations shown

ASLAN Selected sites

Tokyo

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 28, 2018Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions